HSP90B2P and B-cell non-Hodgkin lymphoma: These data suggest that the upregulation of cytosolic, ER, and mitochondrial HSP homologs is a normal HSP response to T cell activation and that this response is dysregulated in B-cell non-Hodgkin’s lymphoma patients.